Healing & regenerative · Peptide
BPC-157
Also known as Body Protection Compound
A research peptide widely explored for tendon, gut and tissue healing.
Status as of 2026-07 · reclassification ≠ FDA approval · educational only, not medical advice.
The signal it sends
Appears to promote new blood-vessel growth (angiogenesis) and modulate healing pathways at injury sites.
Benefits & effects studied
- Tendon/ligament recovery interest
- Gut-protective signals
- Anti-inflammatory in models
Research state
Strong animal data; human evidence very limited. Not an approved medicine.
Dosing & pharmacokinetics
Typically daily subcutaneous in protocols (clinic-supervised). Half-life: Short (hours); dosed daily in research use.
Dosing information is educational only. BPC-157 decisions belong with a licensed clinician — Jevity does not recommend or supply dosing.
History & discovery
First described early 1990s by Predrag Sikiric and colleagues (University of Zagreb, Croatia) Origin: Discovered by Predrag Sikiric's team at the University of Zagreb, who isolated it from a larger protein found in human gastric juice while searching for a substance with broad healing/protective effects; first described in 1993..
Molecular structure
A synthetic 15-amino-acid peptide (pentadecapeptide, sequence GEPPPGKPADDAGLV) derived from a fragment of a protein in human gastric juice.
Frequently asked questions
Is BPC-157 FDA-approved?
Not FDA-approved — research use only; under 503A review (PCAC Jul 2026) On Jevity's evidence scale, BPC-157 is graded "Animal data only". Reclassification for compounding is not the same as FDA approval.
What is BPC-157 used for?
A research peptide widely explored for tendon, gut and tissue healing. Appears to promote new blood-vessel growth (angiogenesis) and modulate healing pathways at injury sites. Studied effects include: Tendon/ligament recovery interest; Gut-protective signals; Anti-inflammatory in models. This is educational information, not a recommendation to use it.
Is BPC-157 legal in the UAE?
UAE / DHA status: Prescription-only via a DHA-licensed clinic; unsupervised import restricted
Is BPC-157 banned in sport?
WADA status: Prohibited at all times
What is BPC-157's Jevity Score?
BPC-157 has a Jevity Score of 28/100 — a proprietary composite of evidence strength (2/10), regulatory clarity (4/10) and supply verifiability (3/10). It reflects how established and legitimate the compound is, not a recommendation.
BPC-157 is prescription-only or research-only. A licensed clinician must evaluate whether it's appropriate for you.
Book a consult →Related healing & regenerative peptides
Educational information only — not medical advice, a diagnosis, or a recommendation to use any substance or therapy. Regulatory status changes; verify current rules and any personal decision with a licensed clinician. Jevity is operated by Upcapital Global FZCO, Dubai, UAE.